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Low birth weight may be associated with high levels of
cholesterol in later life through genetic factors that affect both
birth weight and cholesterol metabolism. Alterations in choles-
terol synthesis and absorption may play an important role in this
association. We examined birth weight and plasma ratios of a
precursor of cholesterol, lathosterol (an estimate of cholesterol
synthesis), and plant sterols, campesterol and -sitosterol (esti-
mates of cholesterol absorption), to cholesterol in 53 dizygotic
and 58 monozygotic adolescent twin pairs. After adjustment for
current weight, birth weight was not associated with the ratios of
lathosterol, campesterol, and -sitosterol either in the overall
sample [0.07 mol/mmol/kg (95% confidence interval: 0.11
to 0.25), p  0.5; 0.02 mol/mmol/kg (0.33 to 0.37), p 
0.9; and 0.04 mol/mmol/kg (0.23 to 0.15), p  0.8, respec-
tively] or in the intrapair analysis in dizygotic twins [0.27
mol/mmol/kg (0.28 to 0.82), p  0.3; 0.03 mol/mmol/kg
(1.07 to 1.01), p  1.0; and 0.04 mol/mmol/kg (0.56 to
0.64), p  0.9, respectively] or in the intrapair analysis in
monozygotic twins [0.54 mol/mmol/kg (0.09 to 1.18), p 
0.09;0.60 mol/mmol/kg (1.59 to 0.39), p 0.2; and0.43
mol/mmol/kg (0.99 to 0.14), p  0.14, respectively]. Plasma
levels of lathosterol, campesterol, and -sitosterol, which are
indicators of cholesterol synthesis and absorption, thus do not
explain the association of low birth weight with high levels of
total and LDL cholesterol. As an alternative hypothesis, we
suggest that a decrease in cholesterol clearance may play an
important role. (Pediatr Res 52: 868–872, 2002)
Low birth weight is associated with an increased risk of
cardiovascular morbidity and mortality (1, 2). An atherogenic
lipid profile may, in part, explain these associations (3–7). The
association between birth weight and an atherogenic lipid
profile has been attributed to a programmed response to intra-
uterine malnutrition that induces permanent changes in the
structure and function of organs, which cause increased levels
of cholesterol in later life (8). The alternative view is that
genetic factors influencing both birth weight and lipid profile
could explain the relationships between these two variables (9).
Studies in dizygotic and monozygotic (genetically identical)
twin pairs offer a unique opportunity to investigate the influ-
ence of intrauterine and genetic factors. Differences within
dizygotic twin pairs are a function of both genetic and nonge-
netic factors, whereas differences within monozygotic pairs are
caused by nongenetic factors. In our cohort of adolescent twin
pairs, we have previously shown that low birth weight was
associated with high total and LDL cholesterol within dizy-
gotic twin pairs, but with low total and LDL cholesterol within
monozygotic twin pairs (10). These data suggest that the
association of birth weight with total and LDL cholesterol is
strongly influenced by the elimination of genetic factors.
Therefore, these genetic factors play an important role in the
association of low birth weight with elevated levels of total and
LDL cholesterol (10).
The metabolic alterations in cholesterol metabolism that
underlie these changes in plasma lipids are not known. Direct
assessment of cholesterol synthesis is expensive, time consum-
ing, and difficult in large-scale studies, but plasma ratios of
lathosterol (a precursor of cholesterol), and campesterol and
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-sitosterol (plant sterols) to cholesterol are indicators of
whole-body cholesterol synthesis and absorption, respectively
(11–16). In a study in children born preterm, Mortaz et al. (17)
demonstrated that low birth weight was associated with an
increase in cholesterol synthesis, as indicated by an increase in
plasma lathosterol, and a compensatory decrease in cholesterol
absorption, as indicated by a decrease in plasma campesterol.
They interpreted this association as a consequence of intrauter-
ine programming (17). However, both birth weight (18, 19)
and indicators of cholesterol metabolism (20, 21) are influ-
enced by genetic factors. Therefore, the association between
them may also be explained by genetic influences.
To examine the association between birth weight and cho-
lesterol metabolism and the possible influence of genetic fac-
tors, we investigated birth weight and markers of cholesterol
synthesis and absorption in our sample of adolescent dizygotic
and monozygotic twin pairs.
METHODS
Subjects. This study is part of a larger project in which
cardiovascular risk factors were studied in 160 adolescent twin
pairs and their parents (22–25). Addresses of twins living in
Amsterdam and neighboring cities were obtained from city
council population registries. Twins still living with their
biologic parents were contacted by letter. A questionnaire was
used to gather information on various factors, including the use
of medication and smoking behavior. The maternal question-
naire included questions regarding birth weight and gestational
age of their children. Opposite-sex dizygotic twin pairs were
excluded because of the effects of sex differences within a pair
on both birth weight and indicators of cholesterol metabolism.
Subjects using oral contraceptives were also excluded for these
analyses. None of the subjects used any other medication that
may affect plasma concentrations of lathosterol, campesterol,
and -sitosterol. Thus, 53 dizygotic twin pairs (average age
17.0 y) and 58 monozygotic twin pairs (average age 16.0 y)
were eligible for analysis. This study was approved by the
institutional review board, and subjects gave their informed
consent.
Measurements. Height and weight were measured in a
standardized way. After acclimatization, EDTA blood was
obtained between 0830 and 1030 h by venipuncture after
overnight fasting. Plasma was separated from cells after cen-
trifugation for 10 min at 3000 rpm. Concentrations of lathos-
terol, campesterol, and -sitosterol were determined with gas
chromatography on a 30-m  0.25-mm CP Sil 5CB column in
a Chrompack model 438S gas chromatograph (Bergen op
Zoom, The Netherlands), as described previously (25). Con-
centrations were expressed as micromole per liter. In addition,
values were expressed as micromole per millimole of choles-
terol, because the measurements of the sterols are influenced
by plasma cholesterol levels (12–15). Cholesterol values of this
sample (10, 24, 25) were determined using enzymatic methods
(CHOD-PAP kit number 236691, Roche Molecular Biochemi-
cals, Mannheim, Germany). Although some studies investigat-
ing indicators of cholesterol metabolism have used gas chro-
matography to measure cholesterol, the use of enzymatic
methods is in accordance with several studies that validated the
use of lathosterol, campesterol, and -sitosterol as indicators of
cholesterol metabolism (11–13), and with the study of Mortaz
et al. (17) in which an association between birth weight and
indicators of cholesterol metabolism was found in preterm
singletons.
Data analysis. In the overall sample, linear regression anal-
ysis was used to investigate the influence of birth weight on
indicators of cholesterol metabolism after adjustment for age
and sex, and after additional adjustment for current weight. An
interaction analysis was performed to investigate whether zy-
gosity or current weight influenced these associations. Intrapair
analyses were performed to investigate the influence of intra-
uterine and genetic factors (10, 23, 26–31). As a first intrapair
analysis, the paired t test was used to compare twins with the
lowest birth weight from each pair with their co-twins with the
highest birth weight. For this analysis, two dizygotic and two
monozygotic twin pairs had to be excluded, because the birth
weight of the twins within a pair was equal. In addition, linear
regression analysis was used to analyze whether intrapair
differences in birth weight influenced intrapair differences in
indicators of cholesterol metabolism before and after adjust-
ment for differences in current weight (including the four twin
pairs in which the birth weight of the twins within a pair was
equal). Intrapair differences in birth weight were calculated by
randomly subtracting the co-twin with the lowest birth weight
from the co-twin with the highest birth weight or vice vera
(32). Interaction analysis was performed to investigate whether
zygosity or differences in current weight influenced the asso-
ciations between intrapair differences in birth weight and indi-
cators of cholesterol metabolism. A two-tailed p value  0.05
was considered significant. All analyses were performed on a
personal computer using the statistical software package SPSS
version 9.0 (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Lathosterol, campesterol, and -sitosterol (whether ex-
pressed as concentration or as ratio to cholesterol) were not
Table 1. Associations between birth weight and indicators of
cholesterol metabolism in the overall sample of twins
 (95% CI)† p value
Adjusted for age and sex
Lathosterol (mol/L) 0.17 (0.55 to 0.89) 0.6
Campesterol (mol/L) 0.39 (1.75 to 0.97) 0.6
-Sitosterol (mol/L) 0.40 (1.15 to 0.35) 0.3
Lathosterol ratio (mol/mmol)* 0.11 (0.06 to 0.29) 0.2
Campesterol ratio (mol/mmol)* 0.04 (0.38 to 0.30) 0.8
-Sitosterol ratio (mol/mmol)* 0.06 (0.24 to 0.13) 0.5
Adjusted for age, sex and current weight
Lathosterol (mol/L) 0.02 (0.72 to 0.76) 1.0
Campesterol (mol/L) 0.11 (1.50 to 1.28) 0.9
-Sitosterol (mol/L) 0.29 (1.07 to 0.48) 0.6
Lathosterol ratio (mol/mmol)* 0.07 (0.11 to 0.25) 0.5
Campesterol ratio (mol/mmol)* 0.02 (0.33 to 0.37) 0.9
-Sitosterol ratio (mol/mmol)* 0.04 (0.23 to 0.15) 0.8
CI, confidence interval.
* Indicates mol/mmol of total cholesterol.
†  (95% CI) per kilogram birth weight.
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related to birth weight in the overall sample (Table 1, upper
panel). The results were similar after additional adjustment for
current weight (Table 1, lower panel). Interaction analysis
indicated no effect modification by zygosity or current weight
(data not shown).
Comparison between co-twins with the lowest and co-twins
with the highest birth weight. Birth weight and gestational age
were similar in dizygotic and monozygotic twins (Table 2).
The differences in birth weight between the co-twins with the
lowest birth weight and those with the highest birth weight
from each pair were similar for dizygotic and monozygotic
twin pairs (380 g and 306 g, respectively, p  0.2; Table 2).
Lathosterol, campesterol, and -sitosterol (whether expressed
as concentration or as ratio to cholesterol) were similar in the
twins with the lowest and the highest birth weight in both
dizygotic and monozygotic twins.
Associations between intrapair differences in birth weight
and indicators of cholesterol metabolism. To further explore
the relation between birth weight and indicators of cholesterol
metabolism, we determined the associations between intrapair
differences in birth weight and differences in lathosterol,
campesterol, and -sitosterol. Intrapair differences in the indi-
cators of cholesterol metabolism (whether expressed as con-
centration or as ratio to cholesterol) were not related to in-
trapair differences in birth weight in the dizygotic twin pairs
either before or after adjustment for differences in current
weight (Table 3). In the unadjusted intrapair analysis in
monozygotic twins, low birth weight was associated with low
concentrations of lathosterol and high concentrations of
campesterol and -sitosterol. However, only the association
with lathosterol was statistically significant. After controlling
for cholesterol levels by using the ratio of lathosterol to
cholesterol, the intrapair association of birth weight with la-
thosterol was smaller. After additional adjustment for differ-
ences in current weight, the association was of borderline
significance (Table 3). Interaction analysis indicated that the
associations between intrapair differences in birth weight and
differences in lathosterol, campesterol, and -sitosterol (wheth-
er expressed as concentration or as ratio to cholesterol) were
not significantly influenced by zygosity or differences in cur-
rent weight (p  0.2).
Additional analyses. After restricting the analyses to sub-
jects born after a gestational age37 wk, low birth weight was
associated with a decreased ratio of lathosterol to cholesterol
[0.30 mol/mmol/kg (95% confidence interval: 0.04–0.56),
p  0.03]. The results of the intrapair analyses in this sub-
group, however, were similar compared with the results of the
intrapair analyses in the total group. In these subjects, birth
weight was not associated with campesterol and -sitosterol.
Adjustment for gestational age or differences in smoking did
not change the results (data not shown). The results were also
similar if the associations were adjusted for differences in
current body mass index instead of current weight.
DISCUSSION
We studied 53 dizygotic and 58 monozygotic adolescent
twin pairs. We have previously demonstrated in this sample
that low birth weight was associated with high total and LDL
cholesterol within dizygotic twin pairs, but with low total and
LDL cholesterol within monozygotic twin pairs (10). In addi-
tion, indicators of cholesterol metabolism (i.e. lathosterol,
campesterol, and -sitosterol) were related to cholesterol and
current weight in this sample (25). Therefore, this sample
allowed us to investigate whether the association between birth
weight and cholesterol is influenced by cholesterol synthesis or
absorption, and the possible influence of genetic factors. We
could not demonstrate an association of birth weight with
indicators of cholesterol synthesis and absorption either in the
overall sample or in the intrapair analysis in dizygotic and
monozygotic twin pairs.
Several studies have found an association of low birth
weight with high total and LDL cholesterol in singletons (3–5)
and we have previously reported this association in the overall
Table 2. Clinical characteristics of the co-twins with the lowest and the highest birth weight in dizygotic and monozygotic twin pairs
Dizygotic twin pairs Monozygotic twin pairs
Co-twins with
the lowest
birth weight
Co-twins with
the highest
birth weight p Value
Co-twins with
the lowest
birth weight
Co-twins with
the highest
birth weight p Value
Birth weight (g) 2246  493 2626 558  0.001 2319 529 2625 485  0.001
Gestational age (wk) 36 8.4 36 8.4 — 37  2.8 37 2.8 —
No. (male/female) 51 (30/21) 51 (30/21) — 56 (29/27) 56 (29/27) —
Age (y) 17.0  1.7 17.0 1.7 — 16.0  1.8 16.0 1.8 —
Current weight (kg) 59.9 7.8 61.8 10.1 0.09 57.5 9.7 58.6 9.5 0.03
Current BMI (kg/m2) 20.0  1.9 20.3 2.2 0.5 19.5 2.3 19.7 2.3 0.2
Smoking 7 9 — 4 4 —
Total cholesterol (mmol/L) 4.15 0.71 3.99 0.62 0.1 4.23 0.80 4.32 0.79 0.1
Lathosterol (mol/L) 6.27  2.80 6.43 2.58 0.8 6.37 2.13 7.24 3.21 0.10
Campesterol (mol/L) 12.76  5.95 12.51 5.75 0.8 12.42 4.48 11.80 4.78 0.4
-Sitosterol (mol/L) 7.10  3.56 6.94 2.93 0.8 6.96 2.68 6.36 2.33 0.2
Lathosterol ratio* 1.52 0.58 1.65 0.71 0.3 1.55 0.57 1.71 0.79 0.2
Campesterol ratio* 3.17 1.52 3.17 1.41 1.0 3.02 1.15 2.82 1.21 0.3
-Sitosterol ratio* 1.77 0.91 1.76 0.72 0.9 1.68 0.64 1.52 0.60 0.12
Mean  SD. BMI, body mass index. The association between birth weight and total cholesterol has been investigated previously 10.
* Expressed as mol/mmol of total cholesterol.
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sample of twins and in the intrapair analysis in dizygotic twin
pairs (10). In the present study, we could not demonstrate an
association between low birth weight and an increased choles-
terol synthesis or absorption, as indicated by elevated plasma
levels of lathosterol, campesterol, and -sitosterol. We cannot
exclude the possibility that low birth weight may be associated
with other indicators of cholesterol metabolism, such as
squalene, methyl sterols, and cholestanol (33), or with direct
measurements of cholesterol metabolism using radioactive iso-
tope techniques (33). However, many studies have shown that
plasma ratios of lathosterol, campesterol, and -sitosterol to
cholesterol are useful indicators of cholesterol metabolism
(12–16). Therefore, we propose that the association between
low birth weight and high levels of total and LDL cholesterol
may be due to a decreased cholesterol clearance. This could be
investigated by studying the in vivo kinetics of apolipoprotein
B containing lipoproteins using a stable isotope approach (34).
The intrapair association between differences in birth weight
and differences in lathosterol in monozygotic twins may sug-
gest an explanation for our previous finding of an association
of low birth weight with low total and LDL cholesterol after
the elimination of genetic influences (10). However, it should
be noted that this association was only of borderline signifi-
cance. Interestingly, the finding of an association of low birth
weight with low cholesterol levels is in line with a study in rats
that demonstrated lower plasma cholesterol concentrations af-
ter maternal undernutrition (35).
Our results differ from the results from Mortaz et al. (17).
They demonstrated, in preterm infants, that low birth weight
was associated with an increase in cholesterol synthesis, as
indicated by an increase in plasma lathosterol, and a compen-
satory decrease in cholesterol absorption, as indicated by a
decrease in plasma campesterol (17). In our study, we could
not detect these associations. In the total group of subjects,
birth weight was not associated with cholesterol synthesis or
absorption. After restricting the analyses to subjects born after
a gestational age 37 wk, low birth weight was associated
with a decreased, not an increased, ratio of lathosterol to
cholesterol. However, the results of Mortaz et al. may differ
from ours for several reasons. First, the subjects in the study of
Mortaz et al. were born very prematurely (average gestational
age 31.1 wk), whereas our subjects were born after 36.3 wk,
which is considered the term period for a twin pregnancy.
Second, subjects in the study of Mortaz et al. were younger
than our twin subjects (11.2 y versus 16.5 y).
It has been suggested that intrauterine growth in twins is not
comparable to intrauterine growth in singletons. However,
birth weight in twins has been associated with many variables
that have been related to birth weight in singletons, such as
blood pressure (23, 26), diabetes (28, 29), myocardial infarc-
tion (30), and height (31). These studies suggest that differ-
ences in birth weight in twins can be used as a model for
differences in birth weight in singletons.
In summary, we found no evidence that plasma levels of
lathosterol, campesterol, and -sitosterol, which are indicators
of cholesterol synthesis and absorption, can explain the asso-
ciation of low birth weight with high levels of total and LDL
cholesterol. As an alternative hypothesis, we suggest that the
association between low birth weight and high levels of total
and LDL cholesterol is due to a decreased cholesterol
clearance.
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